Women's Health
Joint statement urges professionals to recommend individualized menopause treatment
A joint statement from three medical organizations advised health care professionals to recognize that women experiencing menopause need individualized treatment options.
MELD 3.0 corrects disparity in access to liver transplant for women
An updated MELD 3.0 amends existing sex-based disparities in access to liver transplantation among women, according to a presenter at the American Transplant Congress 2022.
UK study supports extending HPV testing interval
Recent findings suggest that with HPV tests, intervals between cervical screenings can be extended to 5 years after a negative result in women aged 25 to 49 years and even longer for women aged older than 50 years.
Q&A: As Supreme Court weighs abortion rights, OB/GYN recalls practice before Roe v. Wade
The Supreme Court decision on the Dobbs v. Jackson Women’s Health Organization abortion case is expected at the end of June, although a leaked draft opinion indicated that the justices intend to overturn the precedent set by Roe v. Wade.
Trastuzumab deruxtecan extends survival in HER2-low metastatic breast cancer
CHICAGO — Trastuzumab deruxtecan significantly extended PFS and OS among patients with HER2-low metastatic breast cancer, regardless of hormone receptor status, compared with standard of care therapy.
Women at greater risk for more severe adverse events from cancer treatments
Women demonstrated a 34% increased risk for severe adverse events from any cancer treatment compared with men, according to a study published in Journal of Clinical Oncology.
Adding bevacizumab to chemotherapy does not worsen quality of life in breast cancer subset
The addition of bevacizumab to chemotherapy did not appear to be negatively associated with quality of life at 18 months in lymph node-positive or high-risk lymph node-negative breast cancer, according to a study in JAMA Network Open.
Q&A: Anti-abortion laws and implications for pregnant patients with CVD
As the U.S. Supreme Court prepares to issue a decision that could potentially overturn Roe v. Wade, many states are preparing to restrict or eliminate abortion rights for patients, including those with CVD.
Gene linked to survival after anthracyclines, anti-HER2 therapies for breast cancer
Genetic variants of the UACA gene, a critical regulator of tumor suppressor Par-4, appeared associated with OS among patients who received anthracyclines and HER2-targeted therapy, according to a study published in NPJ Breast Cancer.
Travel distance to facility represents barrier to abortion care in US
Women who lived farther from an abortion facility were more likely to experience delays in obtaining abortion care or were unable to access it, according to data published in JAMA Network Open.